BOLD
Income statement / Annual
Last year (2025), Boundless Bio Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Boundless Bio Inc.'s net income was -$58.20 M.
See Boundless Bio Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.25 M
|
$1.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$1.25 M
|
-$1.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$44.85 M
|
$55.27 M
|
$42.64 M
|
$37.16 M
|
$19.28 M
|
$104.37 M
|
$75.90 M
|
$48.77 M
|
| General & Administrative Expenses |
$18.71 M
|
$18.00 M
|
$12.16 M
|
$9.31 M
|
$6.02 M
|
$30.00 M
|
$17.28 M
|
$11.28 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.71 M
|
$18.00 M
|
$12.16 M
|
$9.31 M
|
$6.02 M
|
$30.00 M
|
$17.28 M
|
$11.28 M
|
| Other Expenses |
-$1.25 M
|
-$1.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$62.30 M
|
$72.18 M
|
$54.80 M
|
$46.47 M
|
$25.30 M
|
$134.37 M
|
$93.18 M
|
$60.05 M
|
| Cost And Expenses |
$63.55 M
|
$73.27 M
|
$54.80 M
|
$46.47 M
|
$25.30 M
|
$134.37 M
|
$93.18 M
|
$60.05 M
|
| Interest Income |
$5.36 M
|
$7.89 M
|
$5.28 M
|
$668.00 K
|
$96.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.25 M
|
$1.09 M
|
$957.00 K
|
$942.00 K
|
$682.00 K
|
$7.46 M
|
$3.75 M
|
$1.58 M
|
| EBITDA |
-$62.30 M |
-$64.28 M |
-$53.84 M |
-$45.53 M |
-$24.62 M |
-$121.37 M |
-$88.74 M |
-$58.09 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.36 M
|
$7.90 M
|
$5.36 M
|
$568.00 K
|
$91.00 K
|
$5.55 M
|
$693.00 K
|
$378.00 K
|
| Income Before Tax |
-$58.20 M
|
-$65.36 M
|
-$49.43 M
|
-$45.90 M
|
-$25.21 M
|
-$128.82 M
|
-$92.48 M
|
-$59.67 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$2.25 M
|
$378.00 K
|
| Net Income |
-$58.20 M
|
-$65.36 M
|
-$49.43 M
|
-$45.90 M
|
-$25.21 M
|
-$128.82 M
|
-$90.24 M
|
-$59.67 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.6 |
-3.85 |
-2.22 |
-2.06 |
-1.13 |
-2.93 |
-2.05 |
-1.36 |
| EPS Diluted |
-2.6 |
-3.85 |
-2.22 |
-2.06 |
-1.13 |
-2.93 |
-3.4 |
-5.59 |
| Weighted Average Shares Out |
$22.36 M
|
$16.98 M
|
$22.24 M
|
$22.24 M
|
$22.24 M
|
$44.03 M
|
$44.03 M
|
$44.03 M
|
| Weighted Average Shares Out Diluted |
$22.36 M
|
$16.98 M
|
$22.24 M
|
$22.24 M
|
$22.24 M
|
$44.03 M
|
$26.58 M
|
$10.67 M
|
| Link |
|
|
|
|
|
|
|
|
